U.S. News Evaluated GLP-1 Telehealth Platforms
The inaugural rankings highlight top-rated services for patients seeking FDA-approved weight-loss medications.
Updated on Sept. 22, 2026 in Weight Loss
Live Poll
Do you trust telehealth platforms to provide safe, reliable access to weight-loss medications?
U.S. News has released its first set of ratings for telehealth platforms that provide FDA-approved GLP-1 medications. The analysis evaluated 20 different services to help consumers navigate the growing weight-loss treatment marketplace.
Why it matters
As demand for weight-loss drugs grows, these ratings provide a standardized way for consumers to compare clinical support and insurance assistance across various telehealth providers. The analysis aims to help patients choose platforms that prioritize rigorous health screening and transparency.
Amazon One Medical received a 4.8 rating on a five-point scale, while the platform Found earned a 4.6 rating. The rankings were derived from 14,000 collected data points and feedback from 1,251 U.S. adults.
The players
U.S. News
U.S. News is a media organization that produces consumer advice and rankings across various sectors, including healthcare and education.
Amazon One Medical
Amazon One Medical is a primary care organization that combines in-person and virtual medical services for members.
Found
Found is a telehealth platform focused on providing personalized weight management and obesity treatment plans.
The details
Researchers assessed platforms based on six key performance indicators, including clinical support, transparency, and health screening procedures. The study intentionally excluded companies that provide only compounded GLP-1 medications to focus on those offering FDA-approved options.
Timeline
U.S. News conducted survey research from May to July 2026.
The inaugural telehealth ratings were released on September 22, 2026.
The Big Picture
These ratings follow a pattern set by the FDA-approved GLP-1 medication supply chain and the broader market shift toward digital health services. The assessment framework standardizes quality metrics for a sector previously lacking transparent consumer-facing evaluations.
Patients can use these ratings to identify which platforms offer the most robust clinical support and insurance help before committing to a provider. The assessment simplifies the process of finding legitimate, FDA-approved treatment options while avoiding companies that rely solely on compounded drugs.
The takeaway
Consumers should prioritize platforms that provide comprehensive clinical oversight rather than just medication access. Checking a provider against these standardized ratings can help ensure you receive consistent support throughout your treatment plan.
Further reading
For more information on managing your weight-loss journey, visit the Weight Loss section.
Live Poll
Do you trust telehealth platforms to provide safe, reliable access to weight-loss medications?
